Thorbjorn Krejsgaard
Overview
Explore the profile of Thorbjorn Krejsgaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pallesen E, Gluud M, Vadivel C, Buus T, de Rooij B, Zeng Z, et al.
J Invest Dermatol
. 2023 Mar;
143(9):1757-1768.e3.
PMID: 36889662
Staphylococcus aureus is suspected to fuel disease activity in cutaneous T-cell lymphomas. In this study, we investigate the effect of a recombinant, antibacterial protein, endolysin (XZ.700), on S. aureus skin...
2.
Gluud M, Pallesen E, Buus T, Gjerdrum L, Lindahl L, Kamstrup M, et al.
Blood
. 2022 Sep;
141(2):180-193.
PMID: 36122387
Cutaneous T-cell lymphoma (CTCL) is a devastating lymphoid malignancy characterized by the accumulation of malignant T cells in the dermis and epidermis. Skin lesions cause serious symptoms that hamper quality...
3.
Mathiasen S, Gall-Mas L, Pateras I, Theodorou S, Namini M, Hansen M, et al.
Cell Rep
. 2021 Jun;
35(10):109220.
PMID: 34107253
Several types of pathogenic bacteria produce genotoxins that induce DNA damage in host cells. Accumulating evidence suggests that a central function of these genotoxins is to dysregulate the host's immune...
4.
Komseli E, Pateras I, Krejsgaard T, Stawiski K, Rizou S, Polyzos A, et al.
BMC Genomics
. 2021 May;
22(1):327.
PMID: 33952190
No abstract available.
5.
Willerslev-Olsen A, Gjerdrum L, Lindahl L, Buus T, Pallesen E, Gluud M, et al.
J Invest Dermatol
. 2021 Apr;
141(10):2449-2458.
PMID: 33862068
Staphylococcal enterotoxins are believed to fuel disease activity in cutaneous T-cell lymphoma. Recent data support this by showing that antibiotics inhibit malignant T cells in skin lesions in mycosis fungoides...
6.
Vadivel C, Gluud M, Torres-Rusillo S, Boding L, Willerslev-Olsen A, Buus T, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33466582
Perturbation in JAK-STAT signaling has been reported in the pathogenesis of cutaneous T cell lymphoma (CTCL). JAK3 is predominantly associated with the intra-cytoplasmic part of IL-2Rγc located in the plasma...
7.
Stolearenco V, Namini M, Hasselager S, Gluud M, Buus T, Willerslev-Olsen A, et al.
Front Cell Dev Biol
. 2020 Oct;
8:851.
PMID: 33015047
Cutaneous T-cell lymphoma (CTCL) comprises a group of lymphoproliferative diseases characterized by the accumulation of malignant T cells in chronically inflamed skin lesions. In early stages, the disease presents as...
8.
Stolearenco V, Levring T, Nielsen H, Lindahl L, Fredholm S, Kongsbak-Wismann M, et al.
Dermatology
. 2020 Aug;
237(2):283-290.
PMID: 32799209
Background: The thioredoxin-interacting protein (TXNIP) is involved in cellular metabolism and cell proliferation, and recently, deficient expression of TXNIP has been associated with progression and poor outcome for cancer patients....
9.
Lindahl L, Gluud M, Emmanuel T, Thomsen E, Hu T, Rittig A, et al.
Acta Derm Venereol
. 2020 Jun;
100(16):adv00270.
PMID: 32556351
A prognostic 3-miRNA classifier for early-stage mycosis fungoides has been developed recently, with miR-106b providing the strongest prognostic power. The aim of this study was to investigate the molecular function...
10.
Gluud M, Willerslev-Olsen A, Gjerdrum L, Lindahl L, Buus T, Andersen M, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32414221
Cutaneous T-cell lymphoma (CTCL) represents a heterogeneous group of potentially devastating primary skin malignancies. Despite decades of intense research efforts, the pathogenesis is still not fully understood. In the early...